Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Vulvar Intraepithelial Neoplasia (VIN)
and you are
between 18 and 89
years old
The phase for this study is not defined.
Show me locations

The purpose

The primary objective of this study is to evaluate the incidence of vulva dysplasia recurrence within 12 months of treatment with Carbon Dioxide (CO2) laser ablation or ultrasonic aspiration.

Provided treatments

  • Device: Sonopet Ultrasonic Aspirator
  • Device: CO2 Laser Ablation
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02875561. The sponsor of the trial is University of Colorado, Denver and it is looking for 150 volunteers for the current phase.
Official trial title:
A Randomized Controlled Trial of Ultrasonic Aspiration Versus CO2 Laser Ablation for the Treatment of Vulvar Intraepithelial Neoplasia